Loading insider details...
Beta
Latest Form 4 (May 22, 2026): Grant/Award of 838 ALNY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 838 | n/a |
| May 15, 2026 | Elevance Health, Inc. (ELV) | Grant/Award | 563 | n/a |
| May 14, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 11,250 | $789.8K |
| Mar 23, 2026 | Elevance Health, Inc. (ELV) | Sale | 26 | $7.5K |
| Feb 3, 2026 | Elevance Health, Inc. (ELV) | Grant/Award | 218 | n/a |
| Sep 11, 2025 | Camp4 Therapeutics Corp (CAMP) | Purchase | 1,221,721 | $1.87M |
| Jun 13, 2025 | FRACTYL HEALTH, INC. (GUTS) | Grant/Award | 22,500 | n/a |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 775 | n/a |
| Mar 17, 2025 | FRACTYL HEALTH, INC. (GUTS) | Purchase | 8,550 | $10.0K |
| Mar 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 2,750 | $360.8K |